INS and type 2 diabetes mellitus: Improvements in lipid parameters and blood pressure, as well as improvement of fasting glucose, insulin levels, and reduced progression to type 2 diabetes mellitus were seen in the clinical studies.41, –43 A specific cardiovascular safety trial has not been conducted to date.